HomeQuestion

How long do you trial lifestyle therapy before initiating pharmacologic treatment in a patient with BMI 30–35 without diabetes?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you decide between bariatric surgery and a GLP-1 receptor agonist for patients with metabolic dysfunction-associated steatotic liver disease who have not met weight loss goals after six months of lifestyle interventions?

What do you recommend to your patients to prevent muscle loss when prescribing a GLP-1 agonist for weight loss?

Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?

Are you more likely to recommend medical management for obesity instead of bariatric surgery in patients with preexisting hypothyroidism, given a recent study showing increased risks of complications?

How long do you typically treat patients with phentermine for weight loss and what clinical markers do you follow?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.